Japan Intellectual Property Rights: METHODS FOR TREATING MULTIPLE MYELOMA AND USE OF BIOMARKERS FOR 4-(4-(4-(((2-(2,6-DIOXOPIPERIDIN-3-YL)-1-OXOISOINDOLIN-4-YL)OXY)METHYL)BENZYL)PIPERAZIN-1-YL)-3-FLUOROBENZONITRILE

Japan, April 22 -- CELGENE CORP has got intellectual property rights for 'METHODS FOR TREATING MULTIPLE MYELOMA AND USE OF BIOMARKERS FOR 4-(4-(4-(((2-(2,6-DIOXOPIPERIDIN-3-YL)-1-OXOISOINDOLIN-4-YL)OXY)METHYL)BENZYL)PIPERAZIN-1-YL)-3-FLUOROBENZONITRILE.' Other related details are as follows:

Application Number: JP,2024-067889

Category (FI): C12Q1/6869@Z,G01N33/57505,G01N33/575@A,C12Q1/6813@Z,G01N33/57555,G01N33/5754,A61K31/496,G01N33/5751,G01N33/574@A,A61P35/00,C12Q1/686@Z

Stage: Grant (IP right granted following substantive examination.)

Filing Date: April 19, 2024

Publication Date: Aug. 21, 2024

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication.